{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:06:31Z","timestamp":1788314791161,"version":"build-2803163510"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Juul Labs, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This randomized, open-label, crossover clinical study evaluated nicotine pharmacokinetics (PK) and subjective effects of the JUUL System (JS; Juul Labs, Inc.) with three nicotine concentrations compared to the usual brand (UB) cigarettes in 24 adult smokers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>At five study visits, subjects used either the JS in 59 mg\/mL, JS 18 mg\/mL (two visits), and JS 9 mg\/mL (all tobacco-flavored) or smoked their UB cigarette first during a controlled puffing sequence (CPS) and then ad libitum (5 min) use sessions. Blood samples were taken at specified timepoints for 60 min in each session. The modified Product Evaluation Scale assessed subjective effects 30-min post-use in the CPS session.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maximum plasma nicotine concentration (Cmax-BL), total nicotine exposure (AUC0-60-BL), and rate of plasma nicotine rise were significantly lower for all JS products compared to subjects' UB cigarette in CPS and ad libitum use sessions. In both use sessions these PK parameters were significantly higher for JS 59 mg\/mL compared to 18 and 9 mg\/mL. Subjective measures of cigarette craving relief and \u201cEnough Nicotine\u201d for JS 59 mg\/mL did not differ significantly from UB cigarettes, but JS 18 and 9 mg\/mL were rated significantly lower than JS 59 mg\/mL and UB cigarettes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nicotine exposure and subjective relief were directly related to JS nicotine concentration: higher nicotine concentrations gave rise to significantly greater plasma nicotine levels and relief from craving. Heavier and more dependent smokers may require the greater nicotine delivery of JS 59 mg\/mL to successfully transition away from cigarettes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>It has been suggested that electronic nicotine delivery systems (ENDS) and other alternative nicotine delivery products that more closely mimic the nicotine pharmacokinetics (PK) of cigarettes may facilitate smokers transitioning away from cigarettes. We examined nicotine PK and subjective effects of JUUL System (JS) ENDS with three nicotine concentrations (59, 18 and 9 mg\/mL) compared to combustible cigarettes. Nicotine delivery from JS ENDS was nicotine concentration dependent, with higher nicotine concentrations giving rise to higher nicotine exposure. These findings suggest that heavier and more dependent smokers may require ENDS with nicotine concentrations greater than 20 mg\/mL to successfully transition away from cigarettes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ntr\/ntab001","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T23:20:53Z","timestamp":1609802453000},"page":"947-955","source":"Crossref","is-referenced-by-count":42,"title":["An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers"],"prefix":"10.1093","volume":"23","author":[{"given":"Nicholas I","family":"Goldenson","sequence":"first","affiliation":[{"name":"Juul Labs, Inc., Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Fearon","sequence":"additional","affiliation":[{"name":"whatIF? Consulting Ltd., Harwell, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August R","family":"Buchhalter","sequence":"additional","affiliation":[{"name":"PinneyAssociates, Inc., Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack E","family":"Henningfield","sequence":"additional","affiliation":[{"name":"PinneyAssociates, Inc., Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2021052607103549900_CIT0001","volume-title":"The Health Consequences of Smoking: 50 Years of Progress: a Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"2014"},{"key":"2021052607103549900_CIT0002","volume-title":"Publications and Reports of the Surgeon General. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services Medicine","year":"2010"},{"issue":"12","key":"2021052607103549900_CIT0003","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMp1707409","article-title":"A nicotine-focused framework for public health","volume":"377","author":"Gottlieb","year":"2017","journal-title":"N Engl J Med"},{"key":"2021052607103549900_CIT0004","volume-title":"Clearing the Smoke - Assessing the Science Base for Tobacco Harm Reduction","author":"Institute of Medicine National Academies of Sciences","year":"2001"},{"issue":"11","key":"2021052607103549900_CIT0005","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/add.12659","article-title":"Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit","volume":"109","author":"Hajek","year":"2014","journal-title":"Addiction"},{"key":"2021052607103549900_CIT0006","volume-title":"Public Health Consequences of E-Cigarettes","author":"National Academies of Sciences, Engineering and Medicine England","year":"2018"},{"key":"2021052607103549900_CIT0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yrtph.2018.09.004","article-title":"Nicotine pharmacokinetics of electronic cigarettes: a review of the literature","volume":"100","author":"Fearon","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"issue":"8","key":"2021052607103549900_CIT0008","doi-asserted-by":"crossref","first-page":"e185937","DOI":"10.1001\/jamanetworkopen.2018.5937","article-title":"Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes","volume":"1","author":"Goniewicz","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2021052607103549900_CIT0009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/L17-0315","article-title":"E-Cigarettes and toxin exposure","volume":"167","author":"Shahab","year":"2017","journal-title":"Ann Intern Med"},{"key":"2021052607103549900_CIT0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yrtph.2017.12.010","article-title":"Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting","volume":"92","author":"Walele","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"2021052607103549900_CIT0011","volume-title":"Evidence Review of E-cigarettes and Heated Tobacco Products 2018. A Report Commissioned by Public Health England","author":"Public Health England Administration","year":"2018"},{"key":"2021052607103549900_CIT0012","author":"U.S. Food and Drug Administration Union","year":"2019"},{"issue":"6","key":"2021052607103549900_CIT0013","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/add.14936","article-title":"Nicotine delivery and users' reactions to Juul compared with cigarettes and other e-cigarette products","volume":"115","author":"Hajek","year":"2020","journal-title":"Addiction"},{"issue":"1","key":"2021052607103549900_CIT0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","article-title":"Addiction motivation reformulated: an affective processing model of negative reinforcement","volume":"111","author":"Baker","year":"2004","journal-title":"Psychol Rev"},{"key":"2021052607103549900_CIT0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-publhealth-040617-013849","article-title":"Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives","volume":"39","author":"Abrams","year":"2018","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"2021052607103549900_CIT0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/1064-1297.5.2.137","article-title":"Craving is associated with smoking relapse: findings from three prospective studies","volume":"5","author":"Killen","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"issue":"2","key":"2021052607103549900_CIT0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/adb0000434","article-title":"Evaluating the temporal relationships between withdrawal symptoms and smoking relapse","volume":"33","author":"Robinson","year":"2019","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"2021052607103549900_CIT0018","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ntr\/ntaa086","article-title":"Intensive longitudinal study of the relationship between cigalike e-cigarette use and cigarette smoking among adult cigarette smokers without immediate plans to quit smoking","volume":"21","author":"Pearson","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"2021052607103549900_CIT0019","doi-asserted-by":"crossref","first-page":"107999","DOI":"10.1016\/j.drugalcdep.2020.107999","article-title":"The role of subjective responses in electronic cigarette uptake and substitution in adult smokers","volume":"212","author":"Gades","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"2021052607103549900_CIT0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/ntr\/ntx269","article-title":"Predicting short-term uptake of electronic cigarettes: effects of nicotine, subjective effects, and simulated demand","volume":"20","author":"Tucker","year":"2018","journal-title":"Nicotine Tob Res"},{"issue":"11","key":"2021052607103549900_CIT0021","doi-asserted-by":"crossref","first-page":"e1915494","DOI":"10.1001\/jamanetworkopen.2019.15494","article-title":"Nicotine absorption profile among regular users of a pod-based electronic nicotine delivery system","volume":"2","author":"Yingst","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2021052607103549900_CIT0022","doi-asserted-by":"crossref","DOI":"10.1136\/tobaccocontrol-2019-055475","article-title":"Acute effects of JUUL and IQOS in cigarette smokers","author":"Maloney","year":"2020","journal-title":"Tob Control"},{"key":"2021052607103549900_CIT0023","volume-title":"The approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001\/37\/EC","author":"The European Parliament and the Council of the European Union","year":"2014"},{"issue":"1","key":"2021052607103549900_CIT0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5993\/AJHB.41.1.2","article-title":"E-cigarette nicotine delivery: data and learnings from pharmacokinetic studies","volume":"41","author":"Fearon","year":"2017","journal-title":"Am J Health Behav"},{"issue":"7","key":"2021052607103549900_CIT0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/ntr\/nts265","article-title":"Subjective responses to oral tobacco products: scale validation","volume":"15","author":"Hatsukami","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"6","key":"2021052607103549900_CIT0026","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00204-020-02716-3","article-title":"Trendy e-cigarettes enter Europe: chemical characterization of JUUL pods and its aerosols","volume":"94","author":"Mallock","year":"2020","journal-title":"Arch Toxicol"},{"key":"2021052607103549900_CIT0027","doi-asserted-by":"crossref","DOI":"10.1136\/tobaccocontrol-2019-055500","article-title":"Differences in flavourant levels and synthetic coolant use between USA, EU and Canadian Juul products","author":"Erythropel","year":"2020","journal-title":"Tob Control"},{"issue":"1","key":"2021052607103549900_CIT0028","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41598-020-64414-5","article-title":"A comparison of the electrical characteristics, liquid composition, and toxicant emissions of JUUL USA and JUUL UK e-cigarettes","volume":"10","author":"Talih","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"2021052607103549900_CIT0029","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ntr\/ntv182","article-title":"Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report","volume":"18","author":"Lopez","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2021052607103549900_CIT0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874941001205010041","article-title":"The effect of sensorimotor replacement on smoking cessation and craving","volume":"5","author":"Przulj","year":"2012","journal-title":"Open Addict J"},{"key":"2021052607103549900_CIT0031","first-page":"679","article-title":"Sensory attributes of e-cigarette flavours and nicotine as mediators of interproduct differences in appeal among young adults","volume":"29","author":"Leventhal","year":"2020","journal-title":"Tobacco Control"},{"issue":"5","key":"2021052607103549900_CIT0032","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ntr\/ntz058","article-title":"Impacts of nicotine and flavoring on the sensory perception of E-cigarette aerosol","volume":"22","author":"Pullicin","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2021052607103549900_CIT0033","first-page":"CD000146","article-title":"Nicotine replacement therapy for smoking cessation","author":"Stead","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2021052607103549900_CIT0034","first-page":"CD013308","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021052607103549900_CIT0035","volume-title":"Treating Tobacco Use and Dependence: 2008 Update","author":"Tobacco Use and Dependence Guideline Panel","year":"2008","edition":"2008\/09\/24 ed"},{"issue":"4","key":"2021052607103549900_CIT0036","first-page":"477","article-title":"Single-dose and multiple-dose pharmacokinetics of nicotine 6 mg gum","volume":"19","author":"Hansson","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2021052607103549900_CIT0037","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40360-019-0368-9","article-title":"Effect of nicotine 6\u2009mg gum on urges to smoke, a randomized clinical trial","volume":"20","author":"Hansson","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"18","key":"2021052607103549900_CIT0038","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199511023331807","article-title":"Nicotine medications for smoking cessation","volume":"333","author":"Henningfield","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"2021052607103549900_CIT0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198801073180104","article-title":"Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking","volume":"318","author":"T\u00f8nnesen","year":"1988","journal-title":"N Engl J Med"},{"issue":"18","key":"2021052607103549900_CIT0040","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/archinte.1995.00430180077009","article-title":"Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers","volume":"155","author":"Sachs","year":"1995","journal-title":"Arch Intern Med"},{"key":"2021052607103549900_CIT0041","volume-title":"Smoking Cessation: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"2020"},{"key":"2021052607103549900_CIT0042","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1038\/srep11269","article-title":"Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and na\u00efve users (smokers)","volume":"5","author":"Farsalinos","year":"2015","journal-title":"Sci Rep"},{"key":"2021052607103549900_CIT0043","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1038\/srep04133","article-title":"Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices","volume":"4","author":"Farsalinos","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"2021052607103549900_CIT0044","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ntr\/nts165","article-title":"In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns","volume":"15","author":"Zhang","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"2021052607103549900_CIT0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/add.14884","article-title":"Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users","volume":"115","author":"St Helen","year":"2020","journal-title":"Addiction"},{"issue":"5","key":"2021052607103549900_CIT0046","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ntr\/ntz078","article-title":"How does smoking and nicotine dependence change after onset of vaping? a retrospective analysis of dual users","volume":"22","author":"Martinez","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2021052607103549900_CIT0047","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/s12889-016-3510-2","article-title":"Dependence symptoms and cessation intentions among US adult daily cigarette, cigar, and e-cigarette users, 2012-2013","volume":"16","author":"Rostron","year":"2016","journal-title":"BMC Public Health"},{"issue":"10","key":"2021052607103549900_CIT0048","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/add.15060","article-title":"Dependence on e-cigarettes and cigarettes in a cross-sectional study of US adults","volume":"115","author":"Shiffman","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"2021052607103549900_CIT0049","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ntr\/ntu153","article-title":"Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use","volume":"17","author":"Hajek","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"2021052607103549900_CIT0050","doi-asserted-by":"crossref","first-page":"e0220300","DOI":"10.1371\/journal.pone.0220300","article-title":"Nicotine absorption during electronic cigarette use among regular users","volume":"14","author":"Yingst","year":"2019","journal-title":"PLoS One"}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntab001\/36356617\/ntab001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/23\/6\/947\/38149874\/ntab001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/23\/6\/947\/38149874\/ntab001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T03:11:46Z","timestamp":1621998706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/23\/6\/947\/6104644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntab001","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,1,25]]}}}